ACS
LH icon

Archford Capital Strategies’s Labcorp LH Stock Holding History

Archford Capital Strategies’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-44
Closed -$7K – 387
2019
Q2 		$7K Hold
44
– – ﹤0.01% 433
2019
Q1 		$6K Buy
44
+13
+42% +$1.6K ﹤0.01% 418
2018
Q4 		$3K Hold
31
– – ﹤0.01% 440
2018
Q3 		$5K Hold
31
– – ﹤0.01% 446
2018
Q2 		$5K Hold
31
– – ﹤0.01% 475
2018
Q1 		$4K Buy
+31
New +$4.55K ﹤0.01% 422
2017
Q2 		– Sell
-95
Closed -$12K – 431
2017
Q1 		$12K Sell
95
-14
-13% -$1.66K ﹤0.01% 410
2016
Q4 		$11K Hold
109
– – ﹤0.01% 364
2016
Q3 		$11K Sell
109
-24
-18% -$2.83K ﹤0.01% 367
2016
Q2 		$15K Buy
+133
New +$14.3K 0.01% 347
2016
Q1 		– Sell
-74
Closed -$8K – 412
2015
Q4 		$8K Hold
74
– – ﹤0.01% 484
2015
Q3 		$6K Buy
74
+37
+100% +$3.83K ﹤0.01% 409
2015
Q2 		$4K Buy
37
+27
+270% +$2.81K ﹤0.01% 392
2015
Q1 		$1.14K Buy
+10
New +$1.03K ﹤0.01% 630

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Archford Capital Strategies's LH Position: Q3 2019 in Review

Archford Capital Strategies sold out of Labcorp (LH) in Q3 2019, closing a stake of 44 shares — an estimated $7K sold.

Archford Capital Strategies first reported a position in LH in Q1 2015 and held it in 14 quarters. The position peaked at $15K in Q2 2016. 738 funds tracked by Wall St. Rank hold LH as of Q3 2019.

  • Archford Capital Strategies reported no remaining Labcorp position as of Q3 2019 after selling out during the quarter.
  • Archford Capital Strategies sold 44 Labcorp shares in Q3 2019, an estimated $7K.
  • Archford Capital Strategies first reported a position in Labcorp in Q1 2015 and held it in 14 quarters.
  • Archford Capital Strategies's Labcorp position peaked at $15K in Q2 2016.
  • 738 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on Archford Capital Strategies's 13F filing for Q3 2019, filed 23 Oct 2019.